Integrating neurodevelopmental imaging and genetic designs

Abstract Genetic influences on behaviour are complex and, as such, the effect of any single gene is likely to be modest. The focus of this paper is on integrating neuroimaging measures with genetic designs, where neuroimaging measures may serve as an intermediate phenotype in investigating the effect of single genes on human behaviour, and by extension, in neuropsychiatric disease. To qualify as a potential intermediate phenotype, these measures should meet a number of criteria, including being heritable, implicated in the disorder of interest, being stable over time, and firmly grounded in neuroscience. Furthermore, a number of other factors should be considered in investigating single gene effects to maximize the power of the investigation. Throughout the text, we briefly discuss examples to illustrate each of these points. We end by discussing a recent study of single gene effects on brain morphometric measures in attention deficit hyperactivity disorder (ADHD) to illustrate a number of these points in more detail.

[1]  S. Lipton,et al.  Molecular pathways to neurodegeneration , 2004, Nature Medicine.

[2]  A. Diamond,et al.  Genetic and neurochemical modulation of prefrontal cognitive functions in children. , 2004, The American journal of psychiatry.

[3]  Jan K Buitelaar,et al.  Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[4]  F. Castellanos,et al.  Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes , 2002, Nature Reviews Neuroscience.

[5]  J. Buitelaar,et al.  Deficient response inhibition as a cognitive endophenotype of ADHD. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[6]  J N Giedd,et al.  Lack of an association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: genetic and brain morphometric analyses , 1998, Molecular Psychiatry.

[7]  D. Comings,et al.  Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[8]  M. Johnston,et al.  Neurobiology of Rett syndrome: a genetic disorder of synapse development , 2001, Brain and Development.

[9]  M. Posner,et al.  Assessing the molecular genetics of attention networks , 2002, BMC Neuroscience.

[10]  A. Kluger,et al.  A meta-analysis of the association between DRD4 polymorphism and novelty seeking , 2002, Molecular Psychiatry.

[11]  J. Rapoport,et al.  Anatomic brain abnormalities in monozygotic twins discordant for attention deficit hyperactivity disorder. , 2003, The American journal of psychiatry.

[12]  R S Kahn,et al.  Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls , 2005, Molecular Psychiatry.

[13]  J. Smoller,et al.  Molecular Genetics of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[14]  M. Posner,et al.  Mapping the genetic variation of executive attention onto brain activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Douglas W. Jones,et al.  Genotype Influences In Vivo Dopamine Transporter Availability in Human Striatum , 2000, Neuropsychopharmacology.